Vimarsana
Biggest News Aggregation in the World

Altimmune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Altimmune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Altimmune Today - Breaking & Trending Today

Altimmune (NASDAQ:ALT) Cut to "Neutral" at Guggenheim - Vimarsana News

Altimmune (NASDAQ:ALT) Cut to "Neutral" at Guggenheim

Guggenheim downgraded shares of Altimmune (NASDAQ:ALT – Free Report) from a buy rating to a neutral rating in a research note released on Monday, Marketbeat reports. Several other analysts have also commented on the stock. B. Riley reaffirmed a buy rating and issued a $20.00 price objective on shares of Altimmune in a research report […]

Source: wkrb13.com
Altimmune (NASDAQ:ALT) Shares Up 6.5% - Vimarsana News

Altimmune (NASDAQ:ALT) Shares Up 6.5%

Altimmune, Inc. (NASDAQ:ALT – Get Free Report) shot up 6.5% during trading on Monday . The stock traded as high as $7.37 and last traded at $7.36. 1,032,095 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 5,444,214 shares. The stock had previously closed at $6.91. Analyst Upgrades […]

Altimmune (NASDAQ:ALT) Given New $12.00 Price Target at HC Wainwright - Vimarsana News

Altimmune (NASDAQ:ALT) Given New $12.00 Price Target at HC Wainwright

Altimmune (NASDAQ:ALT – Free Report) had its price target reduced by HC Wainwright from $15.00 to $12.00 in a research note released on Monday, Benzinga reports. They currently have a buy rating on the stock. ALT has been the subject of a number of other research reports. The Goldman Sachs Group initiated coverage on shares […]

Ozempic's cheaper side, weight loss drug competition, Amazon delivery - Vimarsana News

Ozempic's cheaper side, weight loss drug competition, Amazon delivery

Plus, Novo Nordisk's $1 billion bet, and Moderna looks beyond the COVID vaccine,

Source: qz.com
A new Ozempic rival helps patients lose fat, but keep their muscle — the holy grail for a weight-loss drug - Vimarsana News

A new Ozempic rival helps patients lose fat, but keep their muscle — the holy grail for a weight-loss drug

The Ozempic rival helped people lose weight while keeping more of their muscles intact. In a trial, people lost 75% fat and 25% muscle.

Source: yahoo.com